Transcription Factors of CAT1, EFG1, and BCR1 Are Effective in Persister Cells of
BCR1
CAT1
EFG1
HIV patients
biofilm
oral candidiasis
patients under chemotherapy
persister cells
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
01
2021
accepted:
06
07
2021
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
14
9
2021
Statut:
epublish
Résumé
Biofilm is an accumulation of cells, which are formed on mucosal surfaces of the host as well as on medical devices. The inherent resistance of After identifying A total of 77 persister isolates were taken from the oral cavity of HIV patients as well as from patients undergoing chemotherapy. Biofilm intensity in persister isolates separated from HIV-infected patients was different from the non-persister group. The mean fold change of It can be concluded that the most important factor in the production of persister cells is biofilm binding and production, not biofilm development or mature biofilm production, which was found in the expression of
Sections du résumé
BACKGROUND
BACKGROUND
Biofilm is an accumulation of cells, which are formed on mucosal surfaces of the host as well as on medical devices. The inherent resistance of
METHODS
METHODS
After identifying
RESULTS
RESULTS
A total of 77 persister isolates were taken from the oral cavity of HIV patients as well as from patients undergoing chemotherapy. Biofilm intensity in persister isolates separated from HIV-infected patients was different from the non-persister group. The mean fold change of
CONCLUSION
CONCLUSIONS
It can be concluded that the most important factor in the production of persister cells is biofilm binding and production, not biofilm development or mature biofilm production, which was found in the expression of
Identifiants
pubmed: 34512562
doi: 10.3389/fmicb.2021.651221
pmc: PMC8425484
doi:
Types de publication
Journal Article
Langues
eng
Pagination
651221Informations de copyright
Copyright © 2021 Aboualigalehdari, Tahmasebi Birgani, Fatahinia and Hosseinzadeh.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS Pathog. 2012 Feb;8(2):e1002525
pubmed: 22359502
Mol Microbiol. 2011 Nov;82(3):602-18
pubmed: 21923768
Methods Mol Biol. 2016;1333:67-72
pubmed: 26468100
PLoS Pathog. 2018 Oct 18;14(10):e1007301
pubmed: 30335865
Front Microbiol. 2018 May 15;9:980
pubmed: 29867882
Front Microbiol. 2020 Jun 05;11:1117
pubmed: 32582081
Jpn J Infect Dis. 2002 Aug;55(4):122-5
pubmed: 12403909
Mycopathologia. 2016 Feb;181(1-2):41-9
pubmed: 26381156
Antimicrob Agents Chemother. 2010 Jan;54(1):39-44
pubmed: 19841146
Cell Host Microbe. 2013 Jun 12;13(6):632-42
pubmed: 23768488
PLoS One. 2015 Sep 14;10(9):e0137750
pubmed: 26368573
Epidemiol Health. 2020;42:e2020033
pubmed: 32512666
Acta Med Iran. 2014;52(1):9-14
pubmed: 24658980
Science. 2004 Sep 10;305(5690):1622-5
pubmed: 15308767
Front Med (Lausanne). 2018 Feb 13;5:28
pubmed: 29487851
Antimicrob Agents Chemother. 2006 Nov;50(11):3839-46
pubmed: 16923951
Antibiotics (Basel). 2021 Jan 15;10(1):
pubmed: 33467766
Can J Infect Dis Med Microbiol. 2016;2016:8758461
pubmed: 27403171
J Bacteriol. 2010 Dec;192(23):6191-9
pubmed: 20935098
Annu Rev Microbiol. 2008;62:193-210
pubmed: 18537474
Nihon Ishinkin Gakkai Zasshi. 2006;47(3):225-9
pubmed: 16940958
Antimicrob Agents Chemother. 2015 Oct;59(10):6101-12
pubmed: 26195524
Front Microbiol. 2018 Jun 04;9:1196
pubmed: 29915571
Microbiology (Reading). 2008 Oct;154(Pt 10):3061-3072
pubmed: 18832312
Microorganisms. 2020 Jan 22;8(2):
pubmed: 31979032
Antimicrob Agents Chemother. 2011 Sep;55(9):4033-7
pubmed: 21746956
FEMS Microbiol Rev. 2017 May 1;41(3):219-251
pubmed: 28333307
BMC Infect Dis. 2012 Sep 25;12:230
pubmed: 23009343
Microbiol Immunol. 2008 Jan;52(1):16-24
pubmed: 18352908
Mycoses. 2007 Nov;50(6):485-90
pubmed: 17944711
Curr Biol. 2005 Jun 21;15(12):1150-5
pubmed: 15964282
Evolution. 2012 Mar;66(3):933-939
pubmed: 22380453
PLoS One. 2011 Jan 25;6(1):e16218
pubmed: 21283544
J Microbiol Methods. 2018 Apr;147:1-13
pubmed: 29454005
Sci Rep. 2020 Apr 1;10(1):5780
pubmed: 32238858
Adv Biomed Res. 2020 Sep 30;9:50
pubmed: 33457333
Curr Opin Microbiol. 2014 Oct;21:18-21
pubmed: 25090240
Future Microbiol. 2013 Oct;8(10):1325-37
pubmed: 24059922
BMC Infect Dis. 2015 Feb 13;15:57
pubmed: 25887032
PLoS One. 2013 May 13;8(5):e62814
pubmed: 23675428
Mol Cell Proteomics. 2016 Nov;15(11):3488-3500
pubmed: 27644984
PLoS Pathog. 2017 May 22;13(5):e1006405
pubmed: 28542620
Genetics. 2005 Apr;169(4):1807-14
pubmed: 15687275
Biochemistry (Mosc). 2005 Feb;70(2):267-74
pubmed: 15807669
BMC Oral Health. 2020 Dec 1;20(1):347
pubmed: 33256696